Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients

By Brechot J.M.   Chevret S.   Nataf J.   Le Gall C.   Fretault J.   Rochemaure J.   Chastang C.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 385-391

Elsevier

Access to resources Recommend Favorite

Erythrocyte and Platelet Phospholipid Fatty Acids as Markers of Advanced Non-Small Cell Lung Cancer: Comparison with Serum Levels of Sialic Acid, TPS and Cyfra 21-1

By de Castro Javier   Rodriguez Marina   Martinez-Zorzano Vicenta   Hernandez-Hernandez Angel   Llanillo Marcial   Sanchez-Yague Jesus  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 407-418

Informa Healthcare

Access to resources Recommend Favorite

Declines in serum CYFRA21-1 and carcinoembryonic antigen as predictors of chemotherapy response and survival in patients with advanced non-small cell lung cancer

By          

Experimental and Therapeutic Medicine, Vol. 4, Iss. 2, 2012-01 ,pp. : 243-248

Spandidos Publications

Access to resources Recommend Favorite

Decreased levels of serum cytokeratin 19 fragment CYFRA 211 predict objective response to chemotherapy in patients with non-small cell lung cancer

By        

Experimental and Therapeutic Medicine, Vol. 6, Iss. 2, 2013-01 ,pp. : 355-360

Spandidos Publications

Access to resources Recommend Favorite

Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib

By                      

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 685-693

Spandidos Publications

Access to resources Recommend Favorite